The natural history of beryllium sensitization and chronic beryllium disease.

With the advent of in vitro immunologic testing, we can now detect exposed individuals who are sensitized to beryllium and those who have chronic beryllium disease (CBD) with lung pathology and impairment. Earlier detection and more accurate diagnostic tools raise new questions about the natural history of sensitization and granulomatous disease. Preliminary data suggest that early detection identifies people who are sensitized to beryllium and that these individuals are at risk for progressing into clinical disease. This article discusses the historical, recent, and ongoing studies germane to our understanding of CBD natural history, including the immunologic and inflammatory basis of the disease, the environmental and host risk factors for disease progression, biological markers of disease severity and activity that may help predict outcome, and the implications for broad-based workplace screening to identify patients at the earliest stages of beryllium sensitization and disease. ImagesFigure 1. AFigure 1. BFigure 1. CFigure 1. D

[1]  S. Lorch,et al.  United States, Beryllium Case Registry (1952-1966). Review of its methods and utility. , 1967, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[2]  M. Peyton,et al.  Exposure data and epidemiology of the beryllium case registry, 1958. , 1959, A.M.A. archives of industrial health.

[3]  K. Kreiss,et al.  Chronic beryllium disease--from the workplace to cellular immunology, molecular immunogenetics, and back. , 1994, Clinical immunology and immunopathology.

[4]  K. Kreiss,et al.  Epidemiology of beryllium sensitization and disease in nuclear workers. , 1993, The American review of respiratory disease.

[5]  M. Rossman,et al.  Bronchoalveolar lavage in a patient with chronic berylliosis: evidence for hypersensitivity pneumonitis. , 1982, Annals of internal medicine.

[6]  K. Kreiss,et al.  Serum angiotensin converting enzyme activity in chronic beryllium disease. , 1992, The American review of respiratory disease.

[7]  G. Wright.  Chronic Pulmonary Granulomatosis of Beryllium Workers. , 1949, Transactions of the American Clinical and Climatological Association.

[8]  K. Kreiss,et al.  Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history. , 1989, The American review of respiratory disease.

[9]  M R Cullen,et al.  Chronic beryllium disease in a precious metal refinery. Clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume. , 2015, The American review of respiratory disease.

[10]  A. Weber,et al.  Respiratory illness in a population exposed to beryllium. , 1973, The American review of respiratory disease.

[11]  J. Stoeckle,et al.  Chronic beryllium disease. Long-term follow-up of sixty cases and selective review of the literature. , 1969, American Journal of Medicine.

[12]  N. Sprince,et al.  Reversible respiratory disease in beryllium workers. , 1978, The American review of respiratory disease.

[13]  L. Newman,et al.  Significance of the blood beryllium lymphocyte proliferation test. , 1996, Environmental health perspectives.

[14]  D. Lezotte,et al.  Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. , 1991, The Journal of allergy and clinical immunology.

[15]  K. Kreiss,et al.  Screening blood test identifies subclinical beryllium disease. , 1989, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[16]  L. Newman,et al.  Early pulmonary physiologic abnormalities in beryllium disease. , 1993, The American review of respiratory disease.

[17]  A. Seeler.  Treatment of chronic beryllium poisoning. , 1959, A.M.A. archives of industrial health.

[18]  D. Lynch,et al.  Beryllium disease: assessment with CT. , 1994, Radiology.

[19]  J. H. Sterner,et al.  The epidemiology of beryllium intoxication. , 1951, Industrial health monthly.

[20]  L. Newman,et al.  Compartmentalized immune response reflects clinical severity of beryllium disease. , 1994, American journal of respiratory and critical care medicine.

[21]  Hardy Hl.  The disability found in persons exposed to certain beryllium compounds. , 1955 .